Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM-862 Plus Chemotherapy in Metastatic Colorectal Cancer
NCT00006037Phase 2Terminated
- Sponsor
- University of Southern California
- Start
- Nov 1999
- Primary completion
- Nov 2001
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oglufanide disodium in colorectal cancer (CRC), sponsored by University of Southern California. Started Nov 1999; status: terminated.
02
Drugs
oglufanide disodium
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00006037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006037.